(Q51770922)

12 April 2018

title

Diseases that may benefit from manipulating the Th17 pathway. (English)

1 reference

12 April 2018

author name string

Pierre Miossec

series ordinal

1

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 March 2009

1 reference

12 April 2018

European Journal of Immunology

published in

1 reference

12 April 2018

volume

39

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

page(s)

667-669

1 reference

12 April 2018

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Th17: the third member of the effector T cell trilogy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Th17 cells in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin-17: an emerging role in lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

Regulation of inflammatory responses by IL-17F

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

Interleukin-17 acts independently of TNF-alpha under arthritic conditions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

Adverse functions of IL-17A in experimental sepsis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839088

7 January 2021

Identifiers

DOI

10.1002/EJI.200839088

1 reference

12 April 2018

1 reference

12 April 2018